S100A4 and malignant colon neoplasm: To analyze the implication of S100A4 expression in patients receiving adjuvant treatment, we first considered TNM stage III colon cancer patients, as this was the only subgroup with a survival benefit of adjuvant chemotherapy in this study 19.